Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

S&P 500 Q1 earnings estimated growth improves; stocks up for week

Published 27/04/2024, 05:52 am
© Reuters. Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., April 26, 2024.  REUTERS/Brendan McDermid

By Caroline Valetkevitch

NEW YORK (Reuters) - U.S. first-quarter estimated earnings growth is looking stronger at nearly the halfway mark of the reporting period, with corporate results giving a boost to stocks this week after recent weakness.

S&P 500 year-over-year earnings growth for the first quarter of 2024 is now seen at 5.6%, according to LSEG data on Friday. That is up from 4.3% the day before.

The latest estimate is based on results from 229 of the S&P 500 companies and forecasts for the rest, with about 78% of reports beating analysts' earnings expectations.

Some 90% of reports from the heavily-weighted communication services are surpassing Wall Street earnings estimates and 88% of reports from the technology sector are beating.

The S&P 500 is up more than 2% for the week but remains down more than 2% since the end of March.

Helping to drive Friday's gains was a rally in Alphabet (NASDAQ:GOOGL) and Microsoft (NASDAQ:MSFT) shares, a day after both companies reported stronger-than-expected results.

But results overall this earnings season have not been all positive, said Peter Tuz, president of Chase Investment Counsel in Charlottesville, Virginia.

"It's still a little early to draw a lot of conclusions, but I'm going to call this a mixed earnings season," he said.

A disappointing forecast from Meta Platforms earlier this week offset some of the earnings optimism.

Also, shares of Intel (NASDAQ:INTC) on Friday were down sharply after it late Thursday gave a downbeat forecast.

Next week brings results from more big names including Amazon.com (NASDAQ:AMZN) and Apple (NASDAQ:AAPL).

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

LSEG noted that the first-quarter forecast has been impacted heavily by an adjustment for Bristol Myers Squibb because of a $12 billion one-time charge related to its acquisition of Karuna Therapeutics.

Without that one-time item, S&P 500 earnings were expected to have risen 8.7% year-over-year as of Friday, LSEG said.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.